Research Article

Role of Four ABC Transporter Genes in Pharmacogenetic Susceptibility to Breast Cancer in Jordanian Patients

Table 4

Association between different ABCC1 and ABCC2 SNP genotypes and the clinicopathological characteristics of breast cancer (BC).

Clinical characteristicsABCC1ABCC2
rs35626 
GG vs GT vs TT
rs35628 
AA vs AG vs GG
rs4148351 
CC vs CT vs TT
rs2273697 
AA vs AG vs GG
rs3740065 
AA vs AG vs GG
rs717620 
CC vs CT vs TT

Body mass index 0.5350.1160.0680.8130.4610.084

Age at first pregnancy 0.9900.6240.3580.3810.9210.458

Age at BC diagnosis 0.3110.3520.1980.0420.1940.104

Allergy 0.8080.8240.8670.5010.3240.065

Age at menarche 0.2190.8240.3730.8200.7470.611

Breastfeeding status 0.2840.1170.7610.4390.3400.005

Age at menopause 0.4370.6650.3730.1150.1550.251

Family history 0.6690.6050.7620.4720.8910.415

Comorbidity 0.7640.9670.9760.1300.7410.140

Smoking 0.2370.2870.1630.3200.4060.362

Pathological characteristics

Progesterone receptor status 0.2920.5160.2440.6100.8230.423

Estrogen receptor status 0.7300.5500.5620.0130.8390.125

HER2 0.1460.5000.3300.4410.2260.842

IHC profile0.0130.8380.2600.3810.7750.270

Tumor differentiation 0.7540.9400.9630.7680.7180.431

Axillary lymph nodes 0.1130.1840.8170.1380.9890.213

Tumor stage 0.4910.7510.6650.7480.9990.357

Histology classification 0.9630.5020.3480.3010.2940.661

Tumor size 0.8880.0140.9680.7200.5760.922

Lymph node involvement 0.6940.9440.7940.1650.3390.528

Pearson’s chi-squared test was used to determine genotype-phenotype association.
Analysis of variance (ANOVA) test was used to determine genotype-phenotype association.
P value <0.05 was considered as significant.